Skip to main content
Premium Trial:

Request an Annual Quote

ProMetic Life Sciences Grosses $6.4M From Stock Placement

NEW YORK (GenomeWeb News) — ProMetic Life Sciences has closed CA$6.6 million ($6.4 million) by selling 18.9 million subordinate shares for CA$.35 a share, the Montreal-based company said Tuesday.
ProMetic said it issued 13.3 million shares to Paradigm Capital for CA$4.7 million and 5.5 million shares to unidentified US institutional investors for CA$1.9 million.
Rodman & Renshaw Capital Group served as financial advisers for the financing, the company said.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.